Core Viewpoint - The event "Rational Investment Accompanies Me, Entering Listed Companies" aimed to enhance communication between investors and listed companies, promoting rational, value, and long-term investment principles [1] Group 1: Company Overview - Aier Eye Hospital is the largest ophthalmology medical group globally, with plans to operate 900 brand hospitals, eye centers, and clinics by the end of 2024, achieving an annual outpatient volume of 16.94 million and nearly 1.3 million surgeries [2] - The company employs a tiered chain model to efficiently allocate medical resources, improving grassroots medical service levels while meeting diverse patient needs [2] - Aier Eye Hospital has been pursuing international expansion since 2014, acquiring excellent overseas targets to better understand global advancements and integrate advanced ophthalmic technologies into its domestic operations [2] Group 2: Technological Innovation - The company is actively exploring the application of AI technology in ophthalmology, collaborating with research institutions to analyze eye images using AI algorithms, enhancing diagnostic efficiency and accuracy [3] - Aier Eye Hospital is developing AI-assisted wearable devices for myopia prevention in children, which monitor eye usage and provide feedback to parents [2][3] Group 3: Investor Engagement - During the event, investors engaged in discussions about AI applications, talent strategies, and overseas market expansion, reflecting their interest in the company's innovative approaches [2] - The event included a tour of Aier Eye Hospital's facilities, showcasing its achievements in eye health education, medical services, research, and talent development [3]